GRDN
$41.87+4.31%
Guardian Pharmacy Services Inc.Stock · HealthcareRussell 2000 · 0.02% of IWMUS Stock Market · 0.002% of VTIRussell 3000 · 0.001% of IWV
GRDN — Guardian Pharmacy Services Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEE
20.025.030.035.040.045.002.0M$41.87—202420252026
2026-10-20
Price$41.87
MA20$41.67
MA50$40.92
Vol970.0K
Key stats#
Price data
- Price
- $41.87
- YTD price return
- +39.15%
- YTD total return
- +39.15%
- Next earnings
- Nov 9, 2026
- Market cap
- 2.7B
- Enterprise value
- 2.6B
- Shares outstanding
- 63.3M
- 52W low
- $25.02
- 52W high
- $48.33
- From 52W high
- -13.37%
- From 52W low
- +67.38%
- 52W range
- 72%
Volume
- Rel volume
- 0.93×
- 30D volume
- 634.5K
- 30D $ vol
- 27.3M
Fundamentals
- Sales (ttm)
- 1.5B
- Sales/share
- $23.10
- EPS (ttm)
- $1.04
- FCF (ttm)
- 94.4M
- FCF/share
- $1.49
- Book value/share
- $4.07
- Net margin
- 4.50%
- ROE
- 25.58%
- ROA
- 14.86%
- Debt / equity
- 0.00×
- Current ratio
- 1.65
Growth (CAGR, ttm) · 10Y
- Sales
- +10.32%n/an/an/a
Per-share growth (CAGR, ttm) · 10Y
- Price
- +61.78%n/an/an/a
- Total return
- +61.78%n/an/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 40.2×
- Fwd P/E
- 27.5×
- P/S (ttm)
- 1.8×
- P/B (mrq)
- 10.3×
- P/FCF (ttm)
- 28.1×
- EV/EBITDA (fy)
- 24.1×
- EV/Sales (ttm)
- 1.8×
- FCF yield (ttm)
- 3.56%
- Buyback yield (cash, ttm)
- -2.24%
- Shareholder yield (cash, ttm)
- -2.24%
Performance · price return · as of 2026-10-20#
1D
+4.31%
5D
+5.17%
1M
-6.93%
3M
+5.25%
YTD
+39.15%
1Y
+61.72%
5Y
—
Financial statements
Open full GRDN financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
